Blog
Mitochondrial Transfer: A Novel Immune Evasion Mechanism in Cancer
In the intricate dance between the immune system and cancer, tumors often deploy cunning strategies to evade destruction. A groundbreaking 2025 study in Nature has unveiled a startling new tactic: cancer cells transfer their damaged mitochondria to immune cells, effectively sabotaging their ability to fight back. This discovery opens a new frontier in our understanding of immune evasion and presents exciting possibilities for the next generation of cancer immunotherapies.
Introduction
The tumor microenvironment (TME) is a complex battlefield where cancer cells and immune cells vie for dominance. A key player in this struggle is the tumor-infiltrating lymphocyte (TIL), a type of T cell that
…
20th Nov 2025
Reprogramming Regulatory T Cells: A Breakthrough in Cancer Immunotherapy
A New Dawn in Cancer Treatment: Reprogramming the Immune System's Own Soldiers
For decades, the fight against cancer has been a relentless battle of attrition, with treatments like chemotherapy and radiation often causing significant collateral damage to the patient's body. However, a new era of cancer therapy is dawning, one that harnesses the power of our own immune system to fight back. This field, known as cancer immunotherapy, has seen remarkable progress, and a recent breakthrough from scientists at Indiana University School of Medicine is poised to revolutionize how we approach some of the most aggressive forms of the disease.
The Double-Edged Sword: Regulatory T Cells
Our immune s
…
19th Nov 2025
Immune-Checkpoint Inhibition in Cancer Prevention
Harnessing Immune-Checkpoint Inhibition for Cancer Prevention
Immune-checkpoint inhibition (ICI) has emerged as a pivotal strategy in cancer therapy, particularly in the context of tumor prevention. This article delves into a recent study that investigates the role of ICI in prolonging overall survival in cancer-prone mice, emphasizing its potential for sustained immune modulation. By understanding the mechanisms at play, researchers can better harness these insights for human health applications.
Study Summary
The study conducted by A. Wolff (2023) reveals that preventive ICI significantly prolongs the overall survival of cancer-prone mice. The findings sug
…
21st Jul 2025